Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091) - Reijneveld, Jaap C.; Machingura, Abigirl; Coens, Corneel; Taphoorn, Martin J. B.; Taal, Walter; Clement, Paul M.; Idbaih, Ahmed; de Vos, Filip Y. F.; Klein, Martin; Wick, Wolfgang; Mulholland, Paul J.; Lewis, Joanne; et al. (European journal of cancer, 2023)
Online verfügbar: 19. Juni 2023, Artikelversion: 13. Juli 2023